James Investment Research Inc Gilead Sciences, Inc. Transaction History

James Investment Research Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$77.31 - $88.08 $2,551 - $2,906	33 New	33 $3,000
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $31,255 - $34,500	-500 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $6,187 - $6,938	100 Added 25.0%	500 $34,000
Q1 2019 Apr 26, 2019	SELL	$62.53 - $70.05 $671,634 - $752,407	-10,741 Reduced 96.41%	400 $26,000
Q4 2018 Jan 22, 2019	SELL	$60.54 - $79.0 $2.35 Million - $3.06 Million	-38,794 Reduced 77.69%	11,141 $697,000
Q3 2018 Oct 26, 2018	BUY	$71.28 - $78.92 $2.15 Million - $2.38 Million	30,157 Added 152.48%	49,935 $3.86 Million
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $2.33 Million - $2.72 Million	-35,883 Reduced 64.47%	19,778 $1.4 Million
Q1 2018 Apr 12, 2018	BUY	$72.84 - $88.8 $1.1 Million - $1.34 Million	15,137 Added 37.35%	55,661 $4.2 Million
Q4 2017 Jan 23, 2018	BUY	$71.15 - $83.52 $543,870 - $638,426	7,644 Added 23.25%	40,524 $2.9 Million
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $2.37 Million - $2.81 Million	32,880	32,880 $2.66 Million

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.